Polypid Stock Performance
| PYPD Stock | USD 3.37 0.07 2.03% |
On a scale of 0 to 100, PolyPid holds a performance score of 7. The company holds a Beta of 0.57, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PolyPid's returns are expected to increase less than the market. However, during the bear market, the loss of holding PolyPid is expected to be smaller as well. Please check PolyPid's expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether PolyPid's historical price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in PolyPid are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, PolyPid exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 5.7 M | |
| Total Cashflows From Investing Activities | -330 K |
PolyPid Relative Risk vs. Return Landscape
If you would invest 282.00 in PolyPid on May 7, 2025 and sell it today you would earn a total of 62.00 from holding PolyPid or generate 21.99% return on investment over 90 days. PolyPid is currently generating 0.3949% in daily expected returns and assumes 3.9121% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than PolyPid, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
PolyPid Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PolyPid's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PolyPid, and traders can use it to determine the average amount a PolyPid's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.101
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PYPD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.91 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.39 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average PolyPid is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PolyPid by adding it to a well-diversified portfolio.
PolyPid Fundamentals Growth
PolyPid Stock prices reflect investors' perceptions of the future prospects and financial health of PolyPid, and PolyPid fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PolyPid Stock performance.
| Return On Equity | -8.53 | ||||
| Return On Asset | -0.87 | ||||
| Current Valuation | 35.85 M | ||||
| Shares Outstanding | 10.19 M | ||||
| Price To Book | 404.08 X | ||||
| EBITDA | (25.83 M) | ||||
| Cash And Equivalents | 23.78 M | ||||
| Cash Per Share | 1.22 X | ||||
| Total Debt | 9.62 M | ||||
| Debt To Equity | 0.47 % | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (21.96 M) | ||||
| Earnings Per Share | (4.28) X | ||||
| Total Asset | 25.22 M | ||||
| Retained Earnings | (267.33 M) | ||||
About PolyPid Performance
By analyzing PolyPid's fundamental ratios, stakeholders can gain valuable insights into PolyPid's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PolyPid has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PolyPid has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix platform to address unmet medical needs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel. Polypid operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 75 people.Things to note about PolyPid performance evaluation
Checking the ongoing alerts about PolyPid for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PolyPid help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PolyPid had very high historical volatility over the last 90 days | |
| PolyPid has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (29.02 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| PolyPid currently holds about 23.78 M in cash with (21.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.22. | |
| Roughly 26.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 684 shares by Jason Cavalier of Lyra Therapeutics at 8.91 subject to Rule 16b-3 |
- Analyzing PolyPid's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PolyPid's stock is overvalued or undervalued compared to its peers.
- Examining PolyPid's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PolyPid's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PolyPid's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PolyPid's stock. These opinions can provide insight into PolyPid's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PolyPid Stock analysis
When running PolyPid's price analysis, check to measure PolyPid's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PolyPid is operating at the current time. Most of PolyPid's value examination focuses on studying past and present price action to predict the probability of PolyPid's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PolyPid's price. Additionally, you may evaluate how the addition of PolyPid to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |